Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Inflow
Outflow
Net flow
Funds Holding
3,502
Funds Holding Change
-39
Funds Holding Growth
-1%
Value
$1.04T
Holding in Top 10
965
Top 10 Change
-189
Top 10 Growth
-16%
Value Growth
-5%
New
78
Increased
1,576
Reduced
1,647
Closed
82
Capital Inflow
$26.5B
Capital Outflow
$28.4B
Net Capital Flow
-$1.82B
Capital Flow Change
-$15.5B
Calls
$11.7B
Puts
$13.4B
Net Calls
-$1.67B
Put/Call Ratio
1.14